-
-
PDI inhibitor 16F16,≥98% (HPLC), 25mg
-
1-[2-[[(Di
phenylmethylene)imino]oxy]ethyl]-1，2，5，6-tetrahydro-3-pyridinecarboxylic acid hydrochloride hydrochloride， NNC-711 hydrochloride,≥98% (HPLC), 10mg
-
1-[2-[[(Di
phenylmethylene)imino]oxy]ethyl]-1，2，5，6-tetrahydro-3-pyridinecarboxylic acid hydrochloride hydrochloride， NNC-711 hydrochloride,≥98% (HPLC), 5mg
-
MST-312,≥98% (HPLC), 5mg
-
MRS 2395,≥98% (HPLC), 5mg
-
Mirin,≥98% (HPLC), 5mg
-
L-742001 hydrochloride,≥98% (HPLC), 5mg
-
L-742001 hydrochloride,≥98% (HPLC), 1mg
-
L-161，982,≥98% (HPLC), 5mg
-
(2Z，2′Z)-4，4′-[1，3-
Phenylenebis(oxy-4，1-
phenyleneimino)]bis[4-oxo-2-butenoic acid,≥98% (HPLC), 10mg
-
(2Z，2′Z)-4，4′-[1，3-
Phenylenebis(oxy-4，1-
phenyleneimino)]bis[4-oxo-2-butenoic acid,≥98% (HPLC), 25mg
стр.: